vaccines

Evonik in partnership with the U.S. government and Indiana will build a new lipid production facility for mRNA-based therapies.

Pharmaceutical maker Jubilant HollisterStier will also invest $193 million in an expansion of its East Spokane, WA plant.

Moderna will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year at the 50 µg dose level.

Business Facilities' March / April 2021 Issue features a look at the Global Supply Chain and our annual tour of top logistics hubs. Plus, a report from Michigan Governor Gretchen Whitmer.

Billions in private equity and public funding are flowing into the life sciences sector, which is front and center in the battle against the pandemic.

In response to COVID-19, the U.S. International Development Finance Corporation will loan the company $590 million to build a facility in Research Triangle Park.

The investment will bring capital improvements, expansion of manufacturing capacity and capabilities, and advanced technology to the company's DeSoto, KS operations.

LifeLine Foods and Boehringer Ingelheim will each make significant investments at their St. Joseph, MO facilities, totaling more than $34 million.

The global healthcare company will expand its Elkton, VA manufacturing facility to increase HPV vaccine production, creating about 100 new jobs.